Jorge Garcia Borrega

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar et al. · The Lancet Haematology · 2021 · 99 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Reactivation of EBV and CMV in Severe COVID-19—Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients

Jan‐Hendrik Naendrup, Jorge Garcia Borrega, Dennis A. Eichenauer et al. · Journal of Intensive Care Medicine · 2021 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter study

Lucie Probst, Enrico Schalk, Tobias Liebregts et al. · Journal of Intensive Care · 2019 · 63 citations · Full text

Veterinary Medicine, Oncology, Clinical Classification Systems +16

COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis

Moritz L. Schmidbauer, Caroline Ferse, Farid Salih et al. · Journal of Clinical Medicine · 2022 · 27 citations · Full text

Medicine, Infectious Diseases, Neurosurgery +13